GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 14 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $64,000 | +1.6% | 15,071 | 0.0% | 0.00% | – |
| Q1 2021 | $63,000 | +16.7% | 15,071 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +3.8% | 15,071 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | +52.9% | 15,071 | 0.0% | 0.00% | – |
| Q2 2020 | $34,000 | +3300.0% | 15,071 | +1407.1% | 0.00% | – |
| Q4 2019 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |